These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 31622813)

  • 1. Efficacy and safety of tigecycline for Mycobacterium abscessus disease.
    Kwon YS; Levin A; Kasperbauer SH; Huitt GA; Daley CL
    Respir Med; 2019; 158():89-91. PubMed ID: 31622813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical experience in 52 patients with tigecycline-containing regimens for salvage treatment of Mycobacterium abscessus and Mycobacterium chelonae infections.
    Wallace RJ; Dukart G; Brown-Elliott BA; Griffith DE; Scerpella EG; Marshall B
    J Antimicrob Chemother; 2014 Jul; 69(7):1945-53. PubMed ID: 24633206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of Short-Term Tigecycline-Containing Regimens for Mycobacterium abscessus Pulmonary Disease.
    Kim SR; Jang M; Kim SY; Kim DH; Jhun BW
    Antimicrob Agents Chemother; 2022 Oct; 66(10):e0077422. PubMed ID: 36165626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhaled tigecycline is effective against Mycobacterium abscessus in vitro and in vivo.
    Pearce C; Ruth MM; Pennings LJ; Wertheim HFL; Walz A; Hoefsloot W; Ruesen C; Muñoz Gutiérrez J; Gonzalez-Juarrero M; van Ingen J
    J Antimicrob Chemother; 2020 Jul; 75(7):1889-1894. PubMed ID: 32294173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical efficacy and safety of multidrug therapy including thrice weekly intravenous amikacin administration for Mycobacterium abscessus pulmonary disease in outpatient settings: a case series.
    Namkoong H; Morimoto K; Nishimura T; Tanaka H; Sugiura H; Yamada Y; Kurosaki A; Asakura T; Suzuki S; Fujiwara H; Yagi K; Ishii M; Tasaka S; Betsuyaku T; Hoshino Y; Kurashima A; Hasegawa N
    BMC Infect Dis; 2016 Aug; 16():396. PubMed ID: 27506679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rifabutin Acts in Synergy and Is Bactericidal with Frontline Mycobacterium abscessus Antibiotics Clarithromycin and Tigecycline, Suggesting a Potent Treatment Combination.
    Pryjma M; Burian J; Thompson CJ
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29760147
    [No Abstract]   [Full Text] [Related]  

  • 7. Omadacycline as a promising new agent for the treatment of infections with Mycobacterium abscessus.
    Bax HI; de Vogel CP; Mouton JW; de Steenwinkel JEM
    J Antimicrob Chemother; 2019 Oct; 74(10):2930-2933. PubMed ID: 31236595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic otitis media caused by Mycobacterium abscessus spp. massiliense treated with tigecycline in a 10-year-old child.
    Myojin S; Fukuoka K; Kanemaru A; Baba S; Okamoto Y; Suzuki H; Kamada K; Yoshida A; Kikuchi K; Horikoshi Y
    Int J Infect Dis; 2018 Sep; 74():10-12. PubMed ID: 29966711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful Systemic and Topical Treatment of Mycobacterium abscessus Otomastoiditis.
    van Wijk F; Waterval J; van Aerde K; Henriet SSV; Meijer FJA; Borra LC; Aarnoutse RE; van Ingen J
    Antimicrob Agents Chemother; 2019 Dec; 64(1):. PubMed ID: 31611360
    [No Abstract]   [Full Text] [Related]  

  • 10.
    Cheng A; Tsai YT; Chang SY; Sun HY; Wu UI; Sheng WH; Chen YC; Chang SC
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30670428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serial CT findings of Mycobacterium massiliense pulmonary disease compared with Mycobacterium abscessus disease after treatment with antibiotic therapy.
    Kim HS; Lee KS; Koh WJ; Jeon K; Lee EJ; Kang H; Ahn J
    Radiology; 2012 Apr; 263(1):260-70. PubMed ID: 22371609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycobacterial Characteristics and Treatment Outcomes in Mycobacterium abscessus Lung Disease.
    Koh WJ; Jeong BH; Kim SY; Jeon K; Park KU; Jhun BW; Lee H; Park HY; Kim DH; Huh HJ; Ki CS; Lee NY; Kim HK; Choi YS; Kim J; Lee SH; Kim CK; Shin SJ; Daley CL; Kim H; Kwon OJ
    Clin Infect Dis; 2017 Feb; 64(3):309-316. PubMed ID: 28011608
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Kaushik A; Ammerman NC; Martins O; Parrish NM; Nuermberger EL
    Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30962331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amikacin Inhalation as Salvage Therapy for Refractory Nontuberculous Mycobacterial Lung Disease.
    Jhun BW; Yang B; Moon SM; Lee H; Park HY; Jeon K; Kwon OJ; Ahn J; Moon IJ; Shin SJ; Daley CL; Koh WJ
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29661870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nontuberculous Mycobacterial Lung Diseases Caused by Mixed Infection with Mycobacterium avium Complex and Mycobacterium abscessus Complex.
    Shin SH; Jhun BW; Kim SY; Choe J; Jeon K; Huh HJ; Ki CS; Lee NY; Shin SJ; Daley CL; Koh WJ
    Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30104265
    [No Abstract]   [Full Text] [Related]  

  • 16. Establishment and Validation of Galleria mellonella as a Novel Model Organism To Study Mycobacterium abscessus Infection, Pathogenesis, and Treatment.
    Meir M; Grosfeld T; Barkan D
    Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29437630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A shorter treatment duration may be sufficient for patients with Mycobacterium massiliense lung disease than with Mycobacterium abscessus lung disease.
    Lyu J; Kim BJ; Kim BJ; Song JW; Choi CM; Oh YM; Lee SD; Kim WS; Kim DS; Shim TS
    Respir Med; 2014 Nov; 108(11):1706-12. PubMed ID: 25245792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 18 Cases of pulmonary Mycobacterium abscessus: Clinical difference depending on the presence or absence of Mycobacterium avium complex.
    Furuta K; Ito A; Ishida T; Ito Y; Sone N; Takaiwa T; Yokoyama T; Tachibana H; Arita M; Hashimoto T
    J Infect Chemother; 2016 Sep; 22(9):622-8. PubMed ID: 27430867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Characteristics and Treatment Outcomes of Patients with Acquired Macrolide-Resistant Mycobacterium abscessus Lung Disease.
    Choi H; Kim SY; Kim DH; Huh HJ; Ki CS; Lee NY; Lee SH; Shin S; Shin SJ; Daley CL; Koh WJ
    Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28739795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Intensified Regimen Containing Linezolid Could Improve Treatment Response in
    Li H; Tong L; Wang J; Liang Q; Zhang Y; Chu N; Chen X; Duan H
    Biomed Res Int; 2019; 2019():8631563. PubMed ID: 31828137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.